The conservative view: is it necessary to implant a stent into the dopamine transporter?

por Schmid, D, Koenig, X, Bulusu, S, Schicker, K, Freissmuth, M, Sitte, H H, Sandtner, W
Publicado 2015

GTRAP3-18 serves as a negative regulator of Rab1 in protein transport and neuronal differentiation

por Maier, S, Reiterer, V, Ruggiero, A M, Rothstein, J D, Thomas, S, Dahm, R, Sitte, H H, Farhan, H
Publicado 2009

Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters

por Mayer, F P, Wimmer, L, Dillon‐Carter, O, Partilla, J S, Burchardt, N V, Mihovilovic, M D, Baumann, M H, Sitte, H H
Publicado 2016

Flotillin‐1 interacts with the serotonin transporter and modulates chronic corticosterone response

por Reisinger, S. N., Kong, E., Molz, B., Humberg, T., Sideromenos, S., Cicvaric, A., Steinkellner, T., Yang, J.‐W., Cabatic, M., Monje, F. J., Sitte, H. H., Nichols, B. J., Pollak, D. D.
Publicado 2018

Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse

por Clauss, N. J., Mayer, F. P., Owens, W. A., Vitela, M., Clarke, K. M., Bowman, M. A., Horton, R. E., Gründemann, D., Schmid, D., Holy, M., Gould, G. G., Koek, W., Sitte, H. H., Daws, L. C.
Publicado 2023